Creative Planning
BIIB icon

Creative Planning’s Biogen BIIB Stock Holding History

Creative Planning’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-400
Closed -$3K – 4354
2016
Q1 		$3K Sell
400
-600
-60% -$158K ﹤0.01% 3785
2015
Q4 		$1K Buy
+1,000
New +$287K ﹤0.01% 4180

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Creative Planning's BIIB Position: Q1 2026 in Review

Creative Planning increased its Biogen (BIIB) stake by 30% in Q1 2026, buying an estimated $5.02M and bringing the position to 117,236 shares worth $21.5M. The position accounts for 0.01% of the portfolio, ranked #412.

Creative Planning first reported a position in BIIB in Q2 2013 and has held it in 51 quarters since. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Creative Planning held 117,236 shares of Biogen worth $21.5M as of Q1 2026.
  • Creative Planning bought 27,234 Biogen shares in Q1 2026, an estimated $5.02M.
  • Biogen made up 0.01% of Creative Planning's portfolio in Q1 2026, its #412 holding.
  • Creative Planning first reported a position in Biogen in Q2 2013 and has held it in 51 quarters since.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.